Nanoscale metal–organic frameworks: From synthesis and multifunctional design to anticancer applications
- 1Institute for Frontier Medical Technology, College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, 201620, China
Abstract
Diagnosis and treatment are typically separate procedures, and their integration into theranostics holds great promise for precision medicine. Metal-organic frameworks (MOFs), assembled from metal nodes and organic ligands, are versatile platforms for multifunctional theranostics due to their integratable components and porous structure for loading active species. However, fabricating nanoscale MOFs (NMOFs) is essential for biomedical applications, as nanosize is required to cross physiological barriers for effective delivery. This review provides a critical overview of NMOF synthesis and design strategies for anticancer applications. Synthesis methods are organized from a mechanistic perspective, including self-limiting growth, seed-growing, template-assisted, kinetic-control, and competitive coordination-induced strategies, and are compared in terms of scalability, reproducibility, and pharmaceutical suitability. We then discuss MOF-based single imaging and therapy, imaging-guided drug delivery, and drug-free cancer theranostics. The combination of MOFs with nanozymes, either as carriers or/and intrinsic nanozymes, is also addressed. Finally, the toxicity profile, challenges, and future prospects for translational applications of NMOFs are outlined. In conclusion, the clinical translation of MOF-based theranostics remains in its early stages, and substantially greater efforts are required before high-performance NMOFs can reach clinical application.
Related
- Advanced metal–organic frameworks for next-generation energy storage and conversion: From nanoscale design to widespread applications
- Green synthesis of Nonea lutea-mediated gold nanoparticles with multifunctional biomedical and environmental applications
- Green synthesis of zirconium oxide nanoparticles using Azadirachta indica leaves extract for multifunctional biomedical applications
- Microwave-assisted green synthesis of pistachio shell-derived carbon dots for antioxidant, anticancer, and antibacterial applications
- Metal Oxide Nanoparticles: A Comprehensive Review of Recent Advances in Synthesis Strategies, Characterization and Multifunctional Applications
BibTeX
@article{xiao2026nanoscale,
title = {{Nanoscale metal–organic frameworks: From synthesis and multifunctional design to anticancer applications}},
author = {Tingting Xiao and Yu Luo and Xijian Liu and Linlin Wang and Xue-Bo Yin},
journal = {International journal of pharmaceutics: X},
year = {2026},
month = oct,
doi = {10.1016/j.ijpx.2026.100692},
url = {https://europepmc.org/article/PMC/PMC13717175},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Nanoscale metal–organic frameworks: From synthesis and multifunctional design to anticancer applications
AU - Tingting Xiao
AU - Yu Luo
AU - Xijian Liu
AU - Linlin Wang
AU - Xue-Bo Yin
PY - 2026
DA - 2026/10/17
JO - International journal of pharmaceutics: X
DO - 10.1016/j.ijpx.2026.100692
UR - https://europepmc.org/article/PMC/PMC13717175
AB - Diagnosis and treatment are typically separate procedures, and their integration into theranostics holds great promise for precision medicine. Metal-organic frameworks (MOFs), assembled from metal nodes and organic ligands, are versatile platforms for multifunctional theranostics due to their integratable components and porous structure for loading active species. However, fabricating nanoscale MOFs (NMOFs) is essential for biomedical applications, as nanosize is required to cross physiological barriers for effective delivery. This review provides a critical overview of NMOF synthesis and design strategies for anticancer applications. Synthesis methods are organized from a mechanistic perspective, including self-limiting growth, seed-growing, template-assisted, kinetic-control, and competitive coordination-induced strategies, and are compared in terms of scalability, reproducibility, and pharmaceutical suitability. We then discuss MOF-based single imaging and therapy, imaging-guided drug delivery, and drug-free cancer theranostics. The combination of MOFs with nanozymes, either as carriers or/and intrinsic nanozymes, is also addressed. Finally, the toxicity profile, challenges, and future prospects for translational applications of NMOFs are outlined. In conclusion, the clinical translation of MOF-based theranostics remains in its early stages, and substantially greater efforts are required before high-performance NMOFs can reach clinical application.
SN - 2590-1567
ER -